These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 548209)

  • 21. Schizophrenia and severe tardive dyskinesia responsive to risperidone.
    Kopala LC; Honer WG
    J Clin Psychopharmacol; 1994 Dec; 14(6):430-1. PubMed ID: 7533794
    [No Abstract]   [Full Text] [Related]  

  • 22. Choline and lecithin in the treatment of tardive dyskinesia: preliminary results from a pilot study.
    Gelenberg AJ; Doller-Wojcik JC; Growdon JH
    Am J Psychiatry; 1979 Jun; 136(6):772-6. PubMed ID: 375755
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tiapride in the treatment of tardive dyskinesia: a clinical and biochemical study.
    Perényi A; Arató M; Bagdy G; Frecska E; Szücs R
    J Clin Psychiatry; 1985 Jun; 46(6):229-31. PubMed ID: 2860098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of lecithin on EEG and blood levels of choline.
    Volavka J; Lifshitz K; Friedman E; Sherman KA; Banay-Schwartz M
    Biol Psychiatry; 1983 Oct; 18(10):1175-9. PubMed ID: 6652158
    [No Abstract]   [Full Text] [Related]  

  • 25. Neuroleptic withdrawal in patients meeting criteria for supersensitivity psychosis.
    Singh H; Hunt JI; Vitiello B; Simpson GM
    J Clin Psychiatry; 1990 Aug; 51(8):319-21. PubMed ID: 1974249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxypertine in tardive dyskinesia: an 8-week controlled study.
    Soni SD; Freeman HL; Hussein EM
    Br J Psychiatry; 1984 Jan; 144():48-52. PubMed ID: 6140973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lecithin for tardive dyskinesia.
    Wilbur K; Kulik AV; Brecht TC
    Am J Psychiatry; 1982 Oct; 139(10):1375. PubMed ID: 6127036
    [No Abstract]   [Full Text] [Related]  

  • 28. Buspirone in the treatment of tardive dyskinesia.
    Moss LE; Neppe VM; Drevets WC
    J Clin Psychopharmacol; 1993 Jun; 13(3):204-9. PubMed ID: 8102622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deanol, lithium and placebo in the treatment of tardive dyskinesia. A double-blind crossover study.
    Jus A; Villeneuve A; Gautier J; Jus K; Villeneuve C; Pires P; Villeneuve R
    Neuropsychobiology; 1978; 4(3):140-9. PubMed ID: 340975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tardive dyskinesia: pergolid, a possible therapeutic option].
    Diehl A; Braus DF; Büchel C; Krumm B; Medori R; Gattaz WF
    Psychiatr Prax; 2003 Sep; 30(6):333-7. PubMed ID: 12970819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melanocyte-stimulating-hormone release-inhibiting factor-I and tardive dyskinesia.
    Ehrensing RH; Kastin AJ; Larsons PF; Bishop GA
    Dis Nerv Syst; 1977 Apr; 38(4):303-7. PubMed ID: 14814
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effectiveness of piracetam in tardive dyskinesia - double-blind cross-over controlled trial with a placebo].
    Kabes J; Sikora J; Starý O; Pisvejc J; Hanzlícek L
    Cesk Psychiatr; 1983 Oct; 79(5):339-45. PubMed ID: 6357509
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of tardive dyskinesia with propranolol.
    Schrodt GR; Wright JH; Simpson R; Moore DP; Chase S
    J Clin Psychiatry; 1982 Aug; 43(8):328-31. PubMed ID: 6124534
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment with dimethylaminoethanol (deanol) in neuroleptic induced tardive dyskinesia].
    Kocher R; Hobi V; Linder M; Studer K
    Schweiz Arch Neurol Neurochir Psychiatr; 1980; 126(1):103-9. PubMed ID: 6106283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bilateral deep brain stimulation of the globus pallidus to treat tardive dyskinesia.
    Damier P; Thobois S; Witjas T; Cuny E; Derost P; Raoul S; Mertens P; Peragut JC; Lemaire JJ; Burbaud P; Nguyen JM; Llorca PM; Rascol O;
    Arch Gen Psychiatry; 2007 Feb; 64(2):170-6. PubMed ID: 17283284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ineffectiveness of deanol in tardive dyskinesia: a placebo controlled study.
    de Montigny C; Chouinard G; Annable L
    Psychopharmacology (Berl); 1979 Nov; 65(3):219-23. PubMed ID: 117492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of choline on tardive dyskinesia and other movement disorders.
    Growdon JH
    Psychopharmacol Bull; 1978 Oct; 14(4):55-6. PubMed ID: 151871
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of nifedipine, a calcium channel antagonist, on cognitive function in schizophrenic patients with tardive dyskinesia.
    Schwartz BL; Fay-McCarthy M; Kendrick K; Rosse RB; Deutsch SI
    Clin Neuropharmacol; 1997 Aug; 20(4):364-70. PubMed ID: 9260735
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin E in the treatment of tardive dyskinesia: a replication study.
    Lam LC; Chiu HF; Hung SF
    J Nerv Ment Dis; 1994 Feb; 182(2):113-4. PubMed ID: 8308529
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.